BioHarvest Sciences Inc.
BioHarvest Sciences Inc.
Indice CSE:
Devise:
BioHarvest Sciences Inc. (CSE: BHSC) is a leader in Botanical Synthesis, leveraging its patented technology process to grow plant-based molecules without the need to grow the underlying plant. BioHarvest is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals; as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. To learn more, please visit www.bioharvest.com.
BioHarvest Sciences Inc. (BHSC)
SEDAR Information
Information d'entreprise
Addresse
1140 - 625 Howe St.
Vancouver, BC V6C 2T6
CanadaTéléphone
604-622-1186Fax
604-685-9182Courriel
info@bioharvest.comURL
http://www.bioharvest.comDate d’inscription à la cote
Mardi, août 4, 2015
Agent de transfert
National Securities Administrators Ltd.Vérificateur
BDOCapitalisation
Capitalisation:
574878008Réservé à l'émission:
143801558Company Officers
Ilan Sobel, CEO
Alan Rootenberg, CFO
Yochi Hagay, CTO
Ilana Belzer, COO
Brian Cornblatt, Chief Medical Officer
Zaki Rakib, President, Chairman & Director
David Ryan , Vice President of Investor Relations, Secretary & Director
Bar Moreh, Vice-President, Finance
Malkit Azachi, Vice-President, Research & Development
Michael Sapir, Vice-President, Regulatory Affairs
Jared Turner , Vice-President, D2C Products Business Unit
Matthew Zrebiec, Vice-President, Business Development
Vivien Rakib, Director
Jake Fiddick, Director
David Tsur, Director
Anna Tenstam, Vice-President, Business Development, Cosmeceuticals and Injectables
Communiqués de presse
26/04/2024